Neurology - Medicine.net

Untangling APOE ε4's association to tau tangles

by McGill UniversityCredit: CC0 Public DomainFor years, physicians have been aware that patients carrying the apolipoprotein E4 (APOEε4) gene are at a greater risk of developing Alzheimer's d

Updated on: July 01,2024

Untangling APOE ε4's association to tau tangles

by McGill UniversityCredit: CC0 Public DomainFor years, physicians have been aware that patients carrying the apolipoprotein E4 (APOEε4) gene are at a greater risk of developing Alzheimer's d

Updated on:July 01,2024

Our brains take rhythmic snapshots of the world as we walk

by Matthew Davidson,The ConversationCredit: Pixabay/CC0 Public DomainFor decades, psychology departments around the world have studied human behavior in darkened laboratories that restrict natur

Updated on: March 19,2024

Our brains take rhythmic snapshots of the world as we walk

by Matthew Davidson,The ConversationCredit: Pixabay/CC0 Public DomainFor decades, psychology departments around the world have studied human behavior in darkened laboratories that restrict natur

Updated on:March 19,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

How retrotransposons control the brain

by John Hewitt , Medical XpressCredit: WikipediaAround half of the genome is made up of transposable elements or 'jumping genes' that derive from ancient viral integrations. They persist in va

Updated on: June 01,2024

How retrotransposons control the brain

by John Hewitt , Medical XpressCredit: WikipediaAround half of the genome is made up of transposable elements or 'jumping genes' that derive from ancient viral integrations. They persist in va

Updated on:June 01,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on: June 14,2024

Protein modification of a gene expression regulator can confer neuroprotection against inflammation

by University of Eastern FinlandCredit: Public DomainResearchers at the University of Eastern Finland have found a potential neuroprotective effect of a protein modification that could be a thera

Updated on:June 14,2024

Portable cap can measure cognition with pulsed laser light

by Anne McGovern,Massachusetts Institute of TechnologyFour custom readout integrated circuits are mounted so that they can be placed on metal plating. The Geiger-mode avalanche photodiodes are l

Updated on: February 05,2024

Portable cap can measure cognition with pulsed laser light

by Anne McGovern,Massachusetts Institute of TechnologyFour custom readout integrated circuits are mounted so that they can be placed on metal plating. The Geiger-mode avalanche photodiodes are l

Updated on:February 05,2024

Brain pathways that control dopamine release may influence motor control

by Anne Trafton,Massachusetts Institute of TechnologyStriosomal S-D1 and S-D2 populations form parallel pathways to dopamine-containing nigral neurons. Credit:Current Biology(2024).

Updated on: November 07,2024

Brain pathways that control dopamine release may influence motor control

by Anne Trafton,Massachusetts Institute of TechnologyStriosomal S-D1 and S-D2 populations form parallel pathways to dopamine-containing nigral neurons. Credit:Current Biology(2024).

Updated on:November 07,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024

Elon Musk's brain implant company offers an intriguing glimpse of an internet connecting human minds

by Simon Marvin and Allan McCay,The ConversationCredit: Rice UniversityElon Musk'scompany called Neuralink, launched in 2016, aims toimplant a piece of technologyin people&

Updated on: March 28,2024

Elon Musk's brain implant company offers an intriguing glimpse of an internet connecting human minds

by Simon Marvin and Allan McCay,The ConversationCredit: Rice UniversityElon Musk'scompany called Neuralink, launched in 2016, aims toimplant a piece of technologyin people&

Updated on:March 28,2024

CRISPR helps identify potential Alzheimer's-related protein

by University of TokyoCredit: CC0 Public DomainExperts at the University of Tokyo have identified a new protein in the pathway that leads to Alzheimer's disease. Researchers used the "mo